H.R. 5573 - PRICED Act
- Sponsor:
- Janice D. Schakowsky
- Summary:
- To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 7 years. (by CRS)
- Status:
- The bill has been referred to committee.
PRICED Act
H.R. 5573 — 114th Congress (2015–2016)
- Summary
- To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 7 years. (by CRS)
- Learn More
- At OpenCongress
- Title
- To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 7 years.
- Other Titles
- Price Relief, Innovation, and Competition for Essential Drugs Act
- PRICED Act
- PRICED Act
- Sponsor
- Janice D. Schakowsky
- Co-Sponsors
- Subjects
- Health
- Drug safety, medical device, and laboratory regulation
- Licensing and registrations
- Marketing and advertising
- Related Bills
- Major Actions
Introduced 6/23/2016 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 6/23/2016 6/23/2016 Referred to the House Committee on Energy and Commerce. 6/23/2016 Introduced in House Number Sponsor Date Offered Status
Contributions
- November - December 2014 For $-1,000 Against $6,850
- January - February 2015 For $1,000 Against $32,500
- March - April 2015 For $9,290 Against $119,000
- May - June 2015 For $14,000 Against $101,300
- July - August 2015 For $6,800 Against $61,750
- September - October 2015 For $9,200 Against $89,050
- November - December 2015 For $25,005 Against $105,301
- January - February 2016 For $4,520 Against $114,050
- March - April 2016 For $17,342 Against $162,950
- May - June 2016 For $14,770 Against $206,550
- July - August 2016 For $7,200 Against $43,563
- September - October 2016 For $14,584 Against $144,675
- November - December 2016 For $250 Against $24,250
Votes
Contributions data source: OpenSecrets.org